These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 1959344)
1. Treatment with 1,25(QH)2D3 in predialysis chronic renal failure. Coen G; Mazzaferro S; Ballanti P; Costantini S; Bonucci E; Bondatti F; Manni M; Pasquali M; Sardella D; Taggi F Contrib Nephrol; 1991; 90():183-8. PubMed ID: 1959344 [No Abstract] [Full Text] [Related]
2. Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment. Coen G; Mazzaferro S; Costantini S; Ballanti P; Carrieri MP; Giordano R; Smacchi A; Sardella D; Bonucci E; Taggi F Miner Electrolyte Metab; 1989; 15(5):295-302. PubMed ID: 2811788 [TBL] [Abstract][Full Text] [Related]
3. Bone GLA protein in predialysis chronic renal failure. Effects of 1,25(OH)2D3 administration in a long-term follow-up. Coen G; Mazzaferro S; Bonucci E; Taggi F; Ballanti P; Bianchi AR; Donato G; Massimetti C; Smacchi A; Cinotti GA Kidney Int; 1985 Nov; 28(5):783-90. PubMed ID: 3878905 [TBL] [Abstract][Full Text] [Related]
4. Treatment of secondary hyperparathyroidism of predialysis chronic renal failure with low doses of 1,25(OH)2D3: humoral and histomorphometric results. Coen G; Mazzaferro S; Bonucci E; Ballanti P; Massimetti C; Donato G; Landi A; Smacchi A; Della Rocca C; Cinotti GA Miner Electrolyte Metab; 1986; 12(5-6):375-82. PubMed ID: 3492662 [TBL] [Abstract][Full Text] [Related]
5. Chronic renal failure and vitamin D metabolites: a status report. Christiansen C J Steroid Biochem; 1983 Jul; 19(1B):517-23. PubMed ID: 6310241 [TBL] [Abstract][Full Text] [Related]
6. Low dose calcitriol versus placebo in patients with predialysis chronic renal failure. Nordal KP; Dahl E J Clin Endocrinol Metab; 1988 Nov; 67(5):929-36. PubMed ID: 3182964 [TBL] [Abstract][Full Text] [Related]
7. The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3. Voigts AL; Felsenfeld AJ; Llach F Arch Intern Med; 1983 Jun; 143(6):1205-11. PubMed ID: 6344827 [TBL] [Abstract][Full Text] [Related]
8. Biologic effect of 1,24(R)(OH)2D3 versus 1,25(OH)2D3 administration in chronic renal failure. Coen G; Bondatti F; Donato G; Mazzaferro S; Pasquali M; Rosini S; Sardella D; Taggi F J Steroid Biochem Mol Biol; 1992 Sep; 42(8):823-9. PubMed ID: 1525043 [TBL] [Abstract][Full Text] [Related]
9. Bone mineral density evaluated by dual-energy X-ray absorptiometry after one-year treatment with calcitriol started in the predialysis phase of chronic renal failure. Przedlacki J; Manelius J; Huttunen K Nephron; 1995; 69(4):433-7. PubMed ID: 7777109 [TBL] [Abstract][Full Text] [Related]
10. Procollagen type I C-terminal extension peptide in predialysis chronic renal failure. Coen G; Mazzaferro S; Ballanti P; Bonucci E; Bondatti F; Manni M; Pasquali M; Perruzza I; Sardella D; Spurio A Am J Nephrol; 1992; 12(4):246-51. PubMed ID: 1481872 [TBL] [Abstract][Full Text] [Related]
11. The effect of hemodialysis, vitamin D metabolites and renal transplantation on the skeletal demineralization associated with renal osteodystrophy: a computerized histomorphometric analysis. Main J; Velasco N; Catto GR; Fraser RA; Edward N; Adami S; O'Riordan JL Clin Nephrol; 1986 Dec; 26(6):279-87. PubMed ID: 3542321 [TBL] [Abstract][Full Text] [Related]
12. Plasma insulin-like growth factor-1 and bone formation parameters in predialysis chronic renal failure. Coen G; Mazzaferro S; Ballanti P; Bonucci E; Bondatti F; Pasquali M; Perruzza I; Manni M; Sardella D Miner Electrolyte Metab; 1991; 17(3):153-9. PubMed ID: 1779936 [TBL] [Abstract][Full Text] [Related]
13. No acceleration and possibly slower progression of renal failure during calcitriol treatment in predialysis chronic renal failure. Coen G; Mazzaferro S; Manni M; Fondi G; Perruzza I; Pasquali M; Taggi F Nephrol Dial Transplant; 1994; 9(10):1520. PubMed ID: 7816273 [No Abstract] [Full Text] [Related]
14. Follow-up of long-term treatment of predialysis renal bone disease with 1-alpha-hydroxy-derivatives of vitamin D. Juttmann JR; Birkenhäger-Frenkel DH; Visser TJ; van Krimpen C; Birkenhäger JC J Steroid Biochem; 1983 Jul; 19(1B):511-6. PubMed ID: 6688450 [TBL] [Abstract][Full Text] [Related]
15. Is 1,25-dihydroxy-cholecalciferol harmful to renal function in patients with chronic renal failure? Christiansen C; Rødbro P; Christensen MS; Hartnack B Clin Endocrinol (Oxf); 1981 Sep; 15(3):229-36. PubMed ID: 6273027 [TBL] [Abstract][Full Text] [Related]
16. Renal function during calcitriol therapy in chronic renal failure. Bertoli M; Luisetto G; Ruffatti A; Urso M; Romagnoli G Clin Nephrol; 1990 Feb; 33(2):98-102. PubMed ID: 2311310 [TBL] [Abstract][Full Text] [Related]
17. Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients. D'Haese PC; Couttenye MM; Lamberts LV; Elseviers MM; Goodman WG; Schrooten I; Cabrera WE; De Broe ME Clin Chem; 1999 Sep; 45(9):1548-56. PubMed ID: 10471660 [TBL] [Abstract][Full Text] [Related]
18. Calciuric response to 1,25-(OH)2D3 in early renal failure. Cremer B; Lübbers E; Klooker P; Schmidt-Gayk H; Ritz E Miner Electrolyte Metab; 1985; 11(3):182-5. PubMed ID: 3839286 [TBL] [Abstract][Full Text] [Related]
19. Long-term low-dose calcitriol treatment in predialysis chronic renal failure: can it prevent hyperparathyroid bone disease? Nordal KP; Dahl E; Halse J; Attramadal A; Flatmark A Nephrol Dial Transplant; 1995; 10(2):203-6. PubMed ID: 7753453 [TBL] [Abstract][Full Text] [Related]
20. Calcitriol and calcium carbonate therapy in early chronic renal failure. Bianchi ML; Colantonio G; Campanini F; Rossi R; Valenti G; Ortolani S; Buccianti G Nephrol Dial Transplant; 1994; 9(11):1595-9. PubMed ID: 7870349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]